174 related articles for article (PubMed ID: 17137080)
1. [Pharmacotherapy of obesity].
Schusdziarra V; Erdmann J
Pharm Unserer Zeit; 2006; 35(6):500-4. PubMed ID: 17137080
[No Abstract] [Full Text] [Related]
2. The secret of feeling full.
Gorman C
Time; 2002 Aug; 160(8):52-3. PubMed ID: 12195776
[No Abstract] [Full Text] [Related]
3. Pharmacology of appetite suppression: implication for the treatment of obesity.
Halford JC
Curr Drug Targets; 2001 Dec; 2(4):353-70. PubMed ID: 11732637
[TBL] [Abstract][Full Text] [Related]
4. Appetite-Suppressing and Satiety-Increasing Bioactive Phytochemicals: A Systematic Review.
Stuby J; Gravestock I; Wolfram E; Pichierri G; Steurer J; Burgstaller JM
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31533291
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacotherapy of obesity].
Svendsen OL
Ugeskr Laeger; 2004 Oct; 166(43):3814-7. PubMed ID: 15544112
[No Abstract] [Full Text] [Related]
6. Clinical use of appetite suppressants.
Silverstone T
Drug Alcohol Depend; 1986 Jun; 17(2-3):151-67. PubMed ID: 3527636
[No Abstract] [Full Text] [Related]
7. Obesity, cardiovascular risk and pharmacotherapy.
Ruilope LM; Garcia-Robles R; Moreno B
Blood Press; 2002; 11(5):260-2. PubMed ID: 12458647
[No Abstract] [Full Text] [Related]
8. Implementing antiobesity treatment in a patient with a mood disorder.
Taylor VH
J Psychiatry Neurosci; 2008 Nov; 33(6):E1-2. PubMed ID: 18982178
[No Abstract] [Full Text] [Related]
9. A step towards developing the expertise to control hunger and satiety: regulatory role of satiomem--a membrane proteoglycan.
Upreti RK; Kidwai AM
Neurochem Res; 1995 Apr; 20(4):375-84. PubMed ID: 7651574
[TBL] [Abstract][Full Text] [Related]
10. Binge eating disorder: the search for better treatments.
Yager J
Am J Psychiatry; 2008 Jan; 165(1):4-6. PubMed ID: 18178748
[No Abstract] [Full Text] [Related]
11. [Perspective of obesity pharmacotherapy].
Svačina S; Sucharda P; Stránská Z; Matoulek M
Cas Lek Cesk; 2014; 153(3):127-30. PubMed ID: 24968289
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological aspects of appetite: implications for the treatment of obesity.
Blundell JE; Greenough A
Biomed Pharmacother; 1994; 48(3-4):119-25. PubMed ID: 7993976
[TBL] [Abstract][Full Text] [Related]
13. Centrally acting anorectic drugs: a clinical perspective.
Silverstone T; Goodall E
Am J Clin Nutr; 1992 Jan; 55(1 Suppl):211S-214S. PubMed ID: 1728836
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacotherapy of obesity].
Tripp B; Ludvik B
Wien Med Wochenschr; 2004 Jul; 154(13-14):320-8. PubMed ID: 15368953
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy for the obese patient.
Dickerson LM; Carek PJ
Prim Care; 2009 Jun; 36(2):407-15. PubMed ID: 19501251
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment of obesity: a public health perspective.
Paumgartten FJ
Cad Saude Publica; 2011 Mar; 27(3):405, 404. PubMed ID: 21519691
[No Abstract] [Full Text] [Related]
17. Pharmacotherapy for obesity--promise and uncertainty.
Yanovski SZ
N Engl J Med; 2005 Nov; 353(20):2187-9. PubMed ID: 16291989
[No Abstract] [Full Text] [Related]
18. [Pharmacotherapy for weight loss in patients with type 2 diabetes].
Toubro S
Ugeskr Laeger; 2007 Aug; 169(33):2619-22. PubMed ID: 17725907
[No Abstract] [Full Text] [Related]
19. Pharmacotherapy for weight management.
Palatty PL; Saldanha E
J Assoc Physicians India; 2012 Mar; 60():34-40, 45. PubMed ID: 22799113
[TBL] [Abstract][Full Text] [Related]
20. Effects of sibutramine on binge eating, hunger, and fullness in a laboratory human feeding paradigm.
Mitchell JE; Gosnell BA; Roerig JL; de Zwaan M; Wonderlich SA; Crosby RD; Burgard MA; Wambach BN
Obes Res; 2003 May; 11(5):599-602. PubMed ID: 12740447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
